XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statement Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net Income (Loss) $ (20,097) $ (20,496)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 8,463 7,876
Stock-based compensation expense 31,903 19,979
Amortization of deferred contract costs 517 228
Change in fair value of contingent consideration (894) 410
Deferred tax benefit (1,045) (584)
Provision for uncollectible accounts (121) 599
Non-cash interest expense 138 144
Accretion of discounts on investments, net of amortization of premiums (143) 0
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (1,939) (6,186)
Unbilled receivables (2,363) (1,511)
Funds receivable from payment partners 28,971 19,649
Prepaid expenses, other current assets and other assets (4,421) (1,030)
Funds payable to clients (94,730) (42,347)
Accounts payable, accrued expenses and other current liabilities 1,807 1,121
Contingent consideration 0 (467)
Other liabilities (675) (574)
Deferred revenue (2,785) (2,463)
Net cash used in operating activities (57,414) (25,652)
Cash flows from investing activities:    
Purchase of short-term and long-term investments (58,491) 0
Proceeds from sale of long-term investments 165 0
Capitalization of internally developed software (3,304) (2,812)
Purchases of property and equipment (604) (671)
Net cash used in investing activities (62,234) (3,483)
Cash flows from financing activities:    
Contingent consideration paid for acquisitions 0 (1,207)
Payment of long-term debt issuance costs (783) 0
Proceeds from the issuance of stock under Employee Stock Purchase Plan 1,415 864
Proceeds from exercise of stock options 3,227 6,044
Net cash provided by financing activities 3,859 5,701
Effect of exchange rates changes on cash and cash equivalents 481 320
Net decrease in cash and cash equivalents (115,308) (23,114)
Cash and cash equivalents, beginning of period 654,608 351,177
Cash and cash equivalents, end of period 539,300 328,063
Supplemental disclosures of cash flow and noncash information    
Purchase of property and equipment in accounts payable 120 39
Issuance of common stock upon settlement of restricted stock units 50,115 20,423
Issuance of common stock for retention bonus $ 324 $ 700